| Chair: |
Thomas Shea, MD, University of North Carolina Hospitals, Chapel Hill, NC |
| Chair Elect |
Paul Martin, MD, PhD, Fred Hutchinson Cancer Research Center, Seattle, WA |
| Vice Chairs |
| |
North America: |
Helen Heslop, MD, Baylor College of Medicine Center for Cell and Gene Therapy, Houston, TX |
| |
Europe: |
David Marks, MD, PhD, Bristol Children's Hospital, Bristol, United Kingdom |
| |
Central/South America: |
Carmem Bonfim, MD, Hospital de Clinicas - UFPR, Curitiba, Brazil |
| |
Asia/Africa/Australia: |
Alok Srivastava, MD, FRACP, FRCPA, FRCP, Christian Medical College, Vellore, India |
| Members at Large |
| |
North America: |
Mitchell Horwitz, MD, Duke University, Durham, NC |
| |
|
Michael Lill, MD, Cedars Sinai Medical Center, Los Angeles, CA |
| |
|
Philip McCarthy, MD, Rosewell Park Cancer Institute, Buffalo, NY |
| |
|
Joseph Pidala, MD, MS, H. Lee Moffit Cancer Center and Research Institute, Tampa, FL |
| |
|
Michael Pulsipher, MD, University of Utah, Salt Lake City, UT |
| |
|
Bipin Savani, MD, Vanderbilt University Medical Center, Nashville, TN |
| |
Non North America: |
Jan Cornelissen, MD, PhD, Dr. Daniel Den Hoed Cancer Center, Rotterdam, Netherlands |
| |
|
Ernst Holler, MD, Klinikum der Universitaet Regensburg, Regensburg, Germany |
| |
|
Shinichiro Okamoto, MD, PhD, Keio University, Shinjuku-ku Tokyo, Japan |
| |
|
Miguel Sanz, MD, PhD, Hospital Universitario La Fe, Valencia, Spain |
| |
|
Jeffrey Szer, MD, Royal Melbourne Hospital City Campus, Parkville, Australia |
| |
|
Andre Tichelli, MD, PhD, University Hospital Basel, Basel, Switzerland |